<DOC>
	<DOCNO>NCT00004433</DOCNO>
	<brief_summary>OBJECTIVES : I . Evaluate presume mechanism action low dose pergolide act acutely dopaminergic autoreceptor postsynaptically D2 sit child 7 17 tourette syndrome ( GTS ) . II . Compare tolerability safety pergolide patient standard neuroleptic therapy via naturalist assessment 3-6 month treatment use matched historical control neuroleptic . III . Determine efficacy pergolide tic control patient .</brief_summary>
	<brief_title>Randomized Study Pergolide Children With Tourette Syndrome</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This three part study : part I randomize , double blind , fix single dose study ; part II randomize , open label , stratify study ; part III randomize , double blind , placebo control study . Part I patient randomize receive oral pergolide one three dose level placebo 10 week . Part II patient randomize receive either low high dose pergolide 4 week . Part III patient randomize first receive either pergolide placebo oral fix dos twice daily follow flexible clinically adjust dose next 3 week 2-week placebo run-in . Patients cross receive treatment another 2 week placebo run-in . Total treatment duration 16 week . Patients follow 6 month . Completion date provide represent completion date grant per OOPD record</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Tourette Syndrome</mesh_term>
	<mesh_term>Pergolide</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics DSM IV primary diagnosis Tourette syndrome ( GTS ) Multiple Axis I Axis II diagnose allow Tourette symptom severity great enough warrant medication ( CGI severity index least 4 ) No chronic motor tic disorder transient tic disorder , anorexia nervosa , pervasive developmental disorder , substance/alcohol abuse dependence within past year , schizophrenia psychotic disorder Prior/Concurrent Therapy At least 4 week since prior neuroleptic therapy At least 2 week since prior medication No concurrent neuroleptic therapy psychotropic therapy ( i.e. , antidepressant anticholinergic ) No concurrent medication may alter interact pergolide Patient Characteristics Performance status : Outpatient status Hematopoietic : Normal clinically insignificant value Hepatic : Normal clinically insignificant value Renal : Normal clinically insignificant value Cardiovascular : Normal electrocardiogram Other : No serious unstable medical illness ( i.e. , diabetes , seizure disorder ) ; Must able perform require measurement ( i.e. , low I.Q . ) ; Effective contraception require fertile patient</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2000</verification_date>
	<keyword>Tourette syndrome</keyword>
	<keyword>neurologic psychiatric disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>